Hemophilic Arthropathy—Pathophysiology and Advances in Treatment
Hemophilia is an X-linked genetic disorder that predominantly affects males, with females typically serving as asymptomatic carriers. Hemophilia A results from a deficiency or dysfunction of coagulation factor VIII, while a deficiency in factor IX causes hemophilia B. A less common condition, factor...
Saved in:
| Main Authors: | Katarina Kovač, Ivan Ljudevit Caktaš, Nataša Kalebota, Porin Perić |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Rheumato |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2674-0621/5/2/5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
by: Kathelijn Fischer, et al.
Published: (2025-05-01) -
Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review
by: Isabela de Oliveira Araujo, et al.
Published: (2025-07-01) -
MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01) -
Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options
by: Bülent Zülfikar, et al.
Published: (2024-10-01) -
Clinical outcomes of total hip and knee arthroplasty for end-stage hemophilic arthropathy in patients with hemophilia: a retrospective study
by: AErGen BaHeTe, et al.
Published: (2025-05-01)